dc.contributor.author | Oztan, Ozgur | |
dc.contributor.author | Turksoy, Vugar A. | |
dc.contributor.author | Deniz, Serdar | |
dc.contributor.author | Iritas, Servet B. | |
dc.contributor.author | Tutkun, Engin | |
dc.date.accessioned | 2024-03-12T19:35:00Z | |
dc.date.available | 2024-03-12T19:35:00Z | |
dc.date.issued | 2022 | |
dc.identifier.issn | 1433-6510 | |
dc.identifier.uri | https://doi.org/10.7754/Clin.Lab.2021.210504 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12450/2791 | |
dc.description.abstract | Background: In this study, we aimed to show that methylated arginines are the predictors of non-clinical atherosclerotic cardiovascular complications in metal workers exposed to Cd. Methods: The 80 Cd-exposed metal workers and 80 non-exposed workers (control) included in the study were available for measuring arginine, ADMA, SDMA, and L-NMMA levels. Results: The average urine Cd levels (CdU) found were 1.03 +/- 0.8 mu g/g creatinine (0.84 +/- 0.65 mu g/L) ranging from 0.01 to 3.00 mu g/g creatinine in the control group and 5.41 +/- 5.2 mu g/g creatinine (4.29 +/- 3.81 mu g/L) ranged from 0.11 to 27.2 mu g/g creatinine in metal workers. On the other hand, the median ratios of the different groups (exposed and control) were found to be 449.35 and 483.88 for arginine/ADMA and 1.28 and 1.33 SDMA/ADMA, respectively. Conclusions: The present study was undertaken to investigate the relationship between cadmium exposure and methylated arginines such as ADMA/SDMA/L-NMMA parameters which is important for the early detection atherosclerotic cardiovascular diseases . (Clin. Lab. 2022;68:xx-xx. DOI: 10.7754/Clin.Lab.2021.210504) | en_US |
dc.description.sponsorship | Yozgat Bozok Univer-sity Scientific Research Foundation [6602b-TF/18-228] | en_US |
dc.description.sponsorship | Acknowledgment: This study was supported by the Yozgat Bozok Univer-sity Scientific Research Foundation (grant No. 6602b-TF/18-228) . | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Clin Lab Publ | en_US |
dc.relation.ispartof | Clinical Laboratory | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Cd exposure | en_US |
dc.subject | CdU | en_US |
dc.subject | methylated arginines | en_US |
dc.subject | atherosclerotic cardiovascular diseases | en_US |
dc.title | The Relationship of Methylated Arginines with Urine Cadmium Levels | en_US |
dc.type | article | en_US |
dc.department | Amasya Üniversitesi | en_US |
dc.authorid | Deniz, Serdar/0000-0002-6941-4813 | |
dc.authorid | İritaş, Servet Birgin/0000-0001-5283-9973; | |
dc.identifier.volume | 68 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 70 | en_US |
dc.identifier.endpage | 77 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.scopus | 2-s2.0-85123312249 | en_US |
dc.identifier.doi | 10.7754/Clin.Lab.2021.210504 | |
dc.department-temp | [Oztan, Ozgur] HLC Med Ctr, Dept Med Management, Ankara, Turkey; [Turksoy, Vugar A.; Tutkun, Engin] Yozgat Bozok Univ, Fac Med, Dept Publ Hlth, Yozgat, Turkey; [Deniz, Serdar] Malatya Turgut Ozal Univ, Fac Med, Dept Publ Hlth, Malatya, Turkey; [Iritas, Servet B.] Amasya Univ, Dept Forens Med, Amasya, Turkey | en_US |
dc.identifier.wos | WOS:000719929300001 | en_US |
dc.identifier.pmid | 35023667 | en_US |
dc.authorwosid | Deniz, Serdar/AAA-6094-2019 | |
dc.authorwosid | İritaş, Servet Birgin/E-6472-2016 | |
dc.authorwosid | TURKSOY, Vugar Ali/AAM-6647-2021 | |